The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CD4+ T cells in PBMC to predict the outcome of anti-PD-1 therapy.
 
Hiroshi Kagamu
Speakers' Bureau - AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Novartis; Ono Pharmaceutical; Pfizer
Research Funding - Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Lilly Japan (Inst); Novartis (Inst); Ono Pharmaceutical (Inst)
 
Ou Yamaguchi
Speakers' Bureau - AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Ono Pharmaceutical
 
Ayako Shiono
No Relationships to Disclose
 
Atsuto Mouri
Speakers' Bureau - AstraZeneca Japan; Boehringer Ingelheim; Chugai Pharma; Lilly Japan; Taiho Pharmaceutical
 
Sachiko Miyauchi
No Relationships to Disclose
 
Harue Utsugi
No Relationships to Disclose
 
Fuyumi Nishihara
No Relationships to Disclose
 
Takahiro Uchida
No Relationships to Disclose
 
Yoshitake Murayama
No Relationships to Disclose
 
Kunihiko Kobayashi
Speakers' Bureau - AstraZeneca Japan; Chugai Pharma